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ABSTRACT
Online controlled experiments, now commonly known as
A/B testing, are crucial to causal inference and data driven
decision making in many internet based businesses. While a
simple comparison between a treatment (the feature under
test) and a control (often the current standard), provides a
starting point to identify the cause of change in Key Perfor-
mance Indicator (KPI), it is often insufficient, as the change
we wish to detect may be small, and inherent variation con-
tained in data may obscure movements in KPI. To have suffi-
cient power to detect statistically significant changes in KPI,
an experiment needs to engage a sufficiently large propor-
tion of traffic to the site, and also last for a sufficiently long
duration. This limits the number of candidate variations
to be evaluated, and the speed new feature iterations. We
introduce more sophisticated experimental designs, specifi-
cally the repeated measures design, including the crossover
design and related variants, to increase KPI sensitivity with
the same traffic size and duration of experiment. In this pa-
per we present FORME (Flexible Online Repeated Measures
Experiment), a flexible and scalable framework for these de-
signs. We evaluate the theoretic basis, design considerations,
practical guidelines and big data implementation. We com-
pare FORME to an existing methodology called mixed effect
model and demonstrate why FORME is more flexible and
scalable. We present empirical results based on both sim-
ulation and real data. Our method is widely applicable to
online experimentation to improve sensitivity in detecting
movements in KPI, and increase experimentation capabil-
ity.
Categories and Subject Descriptors
G.3 [ Probability and Statistics]: Experiment Design
General Terms
Measurement, Experimentation Design, Web search, A/B
Testing
1. INTRODUCTION
Many recent publications attest to the power of using online
A/B testing as the golden rule for making causal inference
in web facing companies large and small. By random assign-
ment of feature to otherwise balanced groups of users and
measuring subsequent changes in user behavior, A/B test-
ing isolates effect of feature change, i.e. the treatment effect
from extraneous sources of variance.
To perform statistical inference in both point estimation and
hypothesis testing for the treatment effect, while controlling
type I error at pre-specified level, we would desire lower type
II error, or equivalently, higher powered experiments. That
is, we wish to be able to detect the effect when there is any.
Running under powered experiments have many perils. Not
only would we miss potentially beneficial effects, we may also
get false confidence about lack of negative effects. Statistical
power increases with larger effect size, and smaller variances.
Let us look at these aspects in turn.
While the actual effect size from a potential new feature may
not be known, we generally select a size that makes business
sense, i.e. one that justifies the cost of feature development
and ongoing maintenance of the code base. Dramatic fea-
tures that drastically alter user behavior and get reflected
in KPI as large effect sizes are few and far in between. Of-
ten the candidate feature has but a small effect on the KPI.
Nonetheless, by accumulating a portfolio of small changes,
a business can achieve big business success. Quote from
Rule #2 of Kohavi et al. (2014), winning is done inch by
inch. This is especially true for mature web facing busi-
nesses where most low hanging fruits were picked already.
In general one expects variance to decrease with increased
sample size. But this is not always true. For online business,
at first glance it may seem that the number of visitors may
be large, and with a casual look people may think the power
to detect any change is large. In reality, however, intrinsic
variation between users is large and may obscure the small
movement in KPI. Variation in measured treatment effect
comes from various sources. Exogenous to the treatment
itself includes user to user variation, e.g. some users from
slower internet connection would always have slower page
load time regardless of what experiments are run. Variance
for some metrics does not decrease over time, instead they
plateau after some period of time (say, two weeks), and run-
ning longer experiments no longer results in corresponding
benefits (see Kohavi et al. 2012, Section 3.4). This poses
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a limitation to any online experimentation platform, where
fast iterations and testing many ideas can reap the most
rewards.
1.1 Motivation
To improve sensitivity of measurement, apart from accurate
implementation and increase sample size and duration, we
can employ statistical methods to reduce variance. Using
the user’s pre-experiment behavior as a baseline for his/her
post-experiment behavior, we can reduce the variance in
measured treatment effect. The experiment setup in a two-
week experiment is shown in Table 1. The typical A/B test
is illustrated in the first row. In the past we have used
regression to reduce variance (CUPED: Controlled Experi-
ments Using Pre-Experiment Data, see Deng et al. (2013))
and have achieved good results, e.g. reducing variance in
number of queries per unique user in a given time period by
40-50%. CUPED has the benefit of having readily available
baseline data“for free”. This improvement is performed with
existing design, using the“free”data as covariates only in the
analysis stage. CUPED is in fact a form of repeated mea-
sures design, where multiple measures on the same subjects
are taken over time. In particular, in the pre-experiment
stage, all users received the default feature C (control) and
none received the new feature T (treatment).
Pre-
Experiment
Experiment
Groups Week0 Week1 Week2
A/B Test
1 - T -
2 - C -
CUPED
1 C - T -
2 C - C -
Parallel
1 T T
2 C C
Crossover
1 T C
2 C T
Re-Randomized
1 C C
2 C T
3 T C
4 T T
Table 1: Repeated Measures Designs
In this paper we extend the idea further by employing the
repeated measures design in different stages of treatment
assignment. The traditional A/B test can be analyzed us-
ing the repeated measures analysis, reporting a “per week”
treatment effect, as show in row 3 “parallel” design in ta-
ble 1. The two week experiment can be considered to be
conducted in two periods, even though users received the
same treatment assignment during both periods. In one
of the new designs, the “crossover” design, in contrast, we
swap treatment assignment half way through the experiment
(row 4 in table 1). Each user will be exposed to both ver-
sions of the treatments, instead of only one of the two in
the usual A/B testing scenario. In sequence, a user will re-
ceive either T followed by C, or C followed by T, with the
flight re-assignment happening at the same moment for all
users. Instead of randomizing treatments to users, we ran-
dom treatment sequences (TC or CT) to users. This way
each user serves as his/her own control in the measurement.
In fact, the crossover design is a type of repeated measures
design commonly used in biomedical research to control for
within-subject variation. We also discuss practical consid-
erations to repeated measures design, with variants to the
crossover design to study the carry over effect, including the
“re-randomized” design (row 5 in table 1).
1.2 Main Contributions
In this paper, we propose a framework called FORME (Flex-
ible Online Repeated Measures Experiment). We made con-
tributions in both novel application and new methodology.
• Novel applications. We propose different experiment
designs with repeated measurement. We demonstrate
through real examples the value of these new designs
comparing to traditional A/B test. Methods for model
assumption checking is also presented. We also com-
pare different designs for practical use and propose a
general workflow for practitioners.
• New Methodology. We review standard repeated mea-
sures models in the framework of mixed effect mod-
els. We present a new method to fit the model that
is scalable to big data. Our method is flexible in
the sense that it makes far less assumptions than tra-
ditional method based on mixed effect model (Bates
et al. 2012a). It naturally handles missing data with-
out missing at random assumption (common in online
experimentation) and still provides unbiased average
treatment effect estimation when mixed effect model
fails. FORME can fit different types of repeated mea-
sures models under the same framework. It also can
be applied to metrics beyond those defined as a simple
average, such as metrics defined as a function of other
metrics.
2. ILLUSTRATION OF FORME
In this sections we will take a close look at several designs,
with a treatment and a control, and with experiments car-
ried out over several periods. Many common online metrics
display different patterns between weekdays and weekends.
Therefore experiments at Bing and many large IT compa-
nies, in general are run for at least a full week to account
for the difference between weekdays and weekends. In the
following section we assume the minimum experimentation
“period” to be one full week, and may extend to up to two
weeks. To facilitate our illustration, in all the derivation
in this section we assume all users appear in all periods,
i.e. no missing measurement. We also restrict ourselves
to metrics that are defined as simple average and assume
treatment and control have the same sample size. We fur-
ther assume treatment effects for each subjects are fixed.
We emphasis this is just for illustration purpose and our
method does not rely on these assumptions and we describe
how we handle missing data and more complicated metrics
in Section 4. Impatient reader who are familiar with re-
peated measures analysis might jump over to Section 5 to
see details of FORME’s model assumptions and comparison
to linear mixed effect model.
Denote the metric value mean in the treatment group as
µT , and that in control as µC . We are interested in the
average treatment effect (ATE) δ = µT − µC which is a
fixed effects in the model in this section. This way, various
designs considered can be examined in the same framework
and easily compared.
We will proceed to show, with theoretical derivations, that
given the same total traffic
• Variance using CUPED ≤ T-Test
• With CUPED: Variance in parallel design ≤ Cumula-
tive Design
• Variance in Crossover design ≤ Parallel Design
Denote observed sample values in the treatment groups and
time periods as ~X, and their means ~β. Note that ~X is a vec-
tor of metric values Xi for different time periods indexed by
i, and the treatment effect δ can be formulated as a function
of ~β depending on model specification. Under the central
limit theorem (CLT), with sufficiently large samples ~X is
asymptotically normal
~X ∼ N(~β,Σ).
The likelihood of ~β given observed data is then
L =
1√
2pi|Σ| 12
exp
(1
2
( ~X − ~β)TΣ−1( ~X − ~β))
To get maximum likelihood estimates (MLE) of ~β, denoted
by βˆ, we seek to minimize -2log(Likelihood)
l = −1
2
( ~X − ~β)TΣ−1( ~X − ~β) + const
Solving ∂l
∂~β
= 0 gives MLE of ~β. And its variance-covariance
matrix is
V ar(βˆ) =
[
∂2l
∂~β∂~βT
]−1
= 1/I(~β)
where Fisher Information
I(~β) = −E
[( ∂
∂~β
logf(X|~β))T logf(X|~β)∣∣∣~β].
In the following sections we will explicitly model the mean
~β as a function of other parameters ~β(~λ), one of the compo-
nents is treatment effect δ, and study expected variance of
the MLEs of ~λ. In fact this is simply:
V ar(λˆ) = I(~λ)−1
=
[(∂β
∂λ
)T
Σ−1E
[
(X − β)(X − β)T ]Σ−1 ∂β
∂λ
]−1
=
[(∂β
∂λ
)T
Σ−1
∂β
∂λ
]−1
Coefficient of variation (CV) defined as the mean over stan-
dard deviation of a metric, determines the sensitivity or the
power of the experiment, given the same sample size. To
study sensitivity or power of various experimental designs,
once we have established that effect size remains relatively
stable across different measuring periods, we can then focus
on variation of estimated effect size solely. Specifically, the
diagonal cell in V ar(λˆ) corresponding to treatment effect δˆ
gives its variance, and is our main focus in the following of
this section.
Analysis from randomized two-group experiments employs
the two sample t-test under the usual A/B testing scenario.
As a gentle introduction we will first look at the t-test using
this notation.
2.1 Two Sample T-test
Let X denote the observed average metric value in control
group and Y denote that in the treatment group. Since
users are randomly assigned into either treatment or control
group, X and Y are thus independent. For simplicity of
notation, we assumed variance in the two group to be equal.
Given large enough sample size, under CLT, and plug in
observed sample variances, we have:[
C
−
T
]
:
[
X
Y
]
∼ N
( [ µ
δ+µ
]
,
[
s2X 0
0 s2Y
] )
where µ is mean metric value in the control group, δ is the
treatment effect compared to the control group, and s2X and
s2Y are variances of X and Y respectively. Here ~λ = (µ, δ),
and the −2logLikelihood, denoted by l, of parameter vector
~β(~λ) = (µ, δ)T given observed data is then
l =
[
X−µ
Y−δ−µ
]T [ s2X 0
0 s2Y
]−1 [
X−µ
Y−δ−µ
]
+ const
Solving for MLE of δ and obtain its variance as
V ar(δˆ)|TTest = s2X + s2Y (1)
It is simply the sum of variances from the treatment and
control groups, which is the asymptotic variance of X − Y .
2.2 Use Pre-experiment Data for Variance Re-
duction
At the analysis level, different models seek to explain the
amount of variation in observed data, which may come from
intrinsic, within-user difference, as well as variation intro-
duced by differential treatment. For example, users that
connect through broadband tend to have faster page load
time than people using dial-up connection. This difference
exists regardless of which treatment conditions the users are
exposed to, and is thus irrelevant when measuring difference
introduced by different treatments. As a result, the mea-
surements on the same users over time tend be positively
correlated.
CUPED and previous work has established that by includ-
ing covariates that are unrelated to the treatment, we can
improve sensitivity and reduce variance of estimated treat-
ment effect. Specifically, the users’ pre-experiment behav-
iors servers as a good baseline for their behavior during the
experiment. By including pre-experiment data as a covariate
in the regression model for treatment effect, we can reduce
the variance of the estimated treatment effect.
Denote the pre-experiment average metric value to be X0
and Y 0 for the later control and treatment groups respec-
tively. By CLT[
C
C
−
C
T
]
:
X0X1
Y 0
Y 1
 ∼ N([ µµ+θµ
δ+µ+θ
]
, [ Σ 00 Σ ]
)
,Σ =
[
s20 ρs0s1
ρs0s1 s
2
1
]
where θ is the difference between the pre-experiment and
experiment periods, i.e. the longitudinal effect, and ρ is the
correlation between the two periods. Here ~λ = (µ, δ, θ). We
assume correlation ρ in both treatment and control groups
to be the same for simplicity. Results do not dependent
on this assumption. Even though the two treatment groups
are still independent, metric value measured on the same
group of users across different time periods are in general
correlated. As we will later see, this correlation effectively
reduces variances on δˆ. Similarly we can solve for MLEs
from solving partial derivative of l = 0 and derive variances
for these estimates.
V ar(δˆ)|CUPED = 2s21
(
1− ρ2) (2)
It’s easy to see (2) has smaller variance of δˆ than (1) by
amount of 2ρ2s21. As users’ behavior is usually consistent
across time, i.e. with non-zero correlation ρ among differ-
ent time periods, this amount is positive. The amount of
variance reduced is ρ2 that of the original variance.
2.3 Cumulative vs. Parallel Design
Note that in the previous design we make no assumption on
the duration of the pre-experiment and experiment periods.
Empirical studies in Deng et al. (2013) have shown that
using one-week pre-experiment data provides similar amount
of variance reduction as using even longer durations. For
simplicity, in practice we recommend using one-week such
data.
And we have mentioned that to capture the difference be-
tween weekday and weekends, we recommend running exper-
iments for whole weeks, typically 14 days. Assuming treat-
ment effect is the same across time, this gives us two ways
of reporting treatment effects, i.e. reporting cumulative ef-
fects for the whole 14 days, and reporting weekly treatment
effect as a weighted average between observed values in the
two weeks. For the latter, using the same notation as above,
we have[
C
C
−
T
T
]
:
X1X2
Y 1
Y 2
 ∼ N([ µµ+θδ+µ
δ+µ+θ
]
, [ Σ 00 Σ ]
)
,Σ =
[
s21 ρs1s2
ρs1s2 s
2
2
]
We can solve for MLE and their variances.
V ar(δˆ)|Parallel = 2 s
2
1s
2
2
(
1− ρ2)
s21 + s
2
2 − 2ρs1s2
(3)
For the former, if the metric value is strictly additive across
time, an example being revenue, under our toy model where
all users appear in both periods, the cumulative treatment
effect would be δ˜ = 2δ, since[
C
−
T
]
:
[
X1+X2
Y 1+Y 2
]
∼ N
( [
2µ+θ
2δ+2µ+θ
]
, [ Σ 00 Σ ]
)
,
Σ = V ar(X1 +X2).
Using (1), variance for the MLE is
V ar(
ˆ˜
δ)|Cumulative = 2V ar(X1 +X2) = 2(s21 + s22 + 2ρs1s2)
(4)
Comparing coefficient of variation (CV) in (3) to (4),
V ar(
ˆ˜
δ)
4δ2
− V ar(δˆ)
δ2
=
(s1 + s2)
2(s1 − s2)2
2δ2(s21 + s
2
2 − 2ρs1s2)
≥ 0
Equality holds when the two periods have identical variance,
i.e. s1 = s2. In other words, for additive metrics which
variation over time is large, reporting weekly metrics alone
will improve metric sensitivity.
For non-additive metrics, such as ratio metrics like Click
Through Rate (CTR), the derivation becomes more involved.
In practice, also there is a lot of non-recurring users. We
opted to show empirical results instead in results section.
Careful readers may have noticed, this method makes a key
assumption that treatment effect δ remains the same in the
two weeks. To check this assumption, we can explicitly test
for δ1 = δ2 by fitting the model this way:
E
X1X2
Y 1
Y 2
 = [ µµ+θδ1+µ
δ2+µ+θ
]
and test for the equivalence of MLEs H0 : δˆ1 = δˆ2. The
parallel design is appropriate if we fail to reject H0.
2.4 Crossover Design
Now with the preliminary background information setup,
we then look at variation reduction achieved through the
crossover design.
The crossover design employs a similar idea to CUPED. In-
stead of using pre-experiment data as the baseline, in cross-
over experiments, each user is exposed to both treatments
sequentially, while the order of treatment groups is deter-
mined randomly. Each user’s behavior while he or she is on
the control condition serves as a baseline for his or her behav-
ior on the treatment condition. By accounting for within-
user variation, analysis based on the crossover design also
reduces variance for the estimated treatment effect.
In causal inference, we often seek to eliminate any confound-
ing factors and isolate the root cause of observed difference.
Due to not observing the counterfactual in the potential out-
come framework(Rosenbaum and Rubin 1983; Morgan and
Winship 2007), randomization is used to make the control
group as the surrogate for counterfactual. This surrogate
only works on average. In reality often some imbalance in
some observed or unobserved factors will remain. Cross-
over design uses each test subject as his or her own control,
thus reducing the influence of confounding covariates, and
achieve better sensitivity in estimating treatment effect.
Distribution of observed sample averages is:[
C
T
−
T
C
]
:
X1X2
Y 1
Y 2
 ∼ N([ µδ+µ+θδ+µ
µ+θ
]
, [ Σ 00 Σ ]
)
,Σ =
[
s21 ρs1s2
ρs1s2 s
2
2
]
Similarly, treatment effect estimate has variance
V ar(δˆ)|Crossover = 2 s
2
1s
2
2
(
1− ρ2)
s21 + s
2
2 + 2ρs1s2
(5)
Comparing (3) to (5), it is obvious that in the crossover
design, treatment effect has smaller variance as long as the
correlation ρ is positive. Similar to CUPED, the amount of
sensitivity improvement is determined by the size of ρ. The
larger the correlation between time periods, the more im-
provement the crossover design has over the parallel design.
The equivalence of treatment effect can be similarly checked
as in section 2.3.
2.5 Absolute or Relative Change?
So far in this paper we considered the absolute treatment dif-
ference δ = µT − µC . In practice we measure thousands of
metrics simultaneously. These metrics may have vastly dif-
ferent magnitude in their treatment effects. Even the same
metric measured over different duration, or over different
sample sizes may have different absolute δ’s. This renders
comparison of effect size across different experiments diffi-
cult. To overcome this difficulty, we often seek to measure
percent delta, %δ = δ
µC
· 100%. The relative change is less
influenced by the base difference and is a more robust mea-
sure of treatment effect. In online experimentation we usu-
ally deal with hundreds of thousands of samples, therefore
CLT still holds and relative change would still have asymp-
totic normality. The additive model described above can be
readily adapted to model relative difference instead of abso-
lute difference, by formulating the expected group means in
the mixed variance-covariance structure model. For exam-
ple, the crossover model with relative treatment effect can
be written as:[
C
T
−
T
C
]
:
[
X¯1
X¯2
Y¯1
Y¯2
]
∼ N
([ µ
µ(1+δ)+θ
µ(1+δ)
µ+θ
]
, [ Σ 00 Σ ]
)
,Σ =
[
s21 ρs1s2
ρs1s2 s
2
2
]
Theoretic derivation to show variance reduction can be com-
plex, but MLE estimates and their variances can be easily
solved using numeric methods.
2.6 The Unified Theme
We illustrated different model designs of FORME. Careful
readers might already noticed that the unified theme here is
to study the joint distribution of ~X and ~Y , which by cen-
tral limit theorem is known to be multivariate normal. Each
model specification maps to the mean vector ~β of this mul-
tivariate normal. Therefore for any mean vector based on a
model specification, we can solve the MLE and estimate its
variance using Fisher’s Information. The difficulty, however,
lies in how to estimate the covariance matrix in general case
with presence of missing data and in general for metrics that
are not defined as simple as average. For crossover design,
in particular, we also need a way to decide whether we can
safely assume the treatment effect in both periods are the
same without any carry over effect. We will address these
in details in Section 3 and Section 4. Section 5 explains why
FORME is more flexible and scalable than existing method
of fitting linear mixed effect model.
3. CARRY OVER EFFECT
The crossover design is not without concerns. An important
assumption in crossover model is that the treatment effect
remains the same in the experimental periods. Since test
subjects randomly receive all combinations of treatments in
sequence, different users will receive difference sequence or
“order” the treatments. It is possible that the order in which
users are exposed to treatments may change the effect. For
an extreme example, suppose our treatment introduced a
bug that results in severely negative user experience, and
these group of users fail to revisit the website in the later
crossover period, the treatment effect is then different in the
two periods. We call this the carry over effect, as the users
exposed to treatment first, and then the control later may
behave differently from the other group.
In some experiments where the treatment condition is less
noticeable to the users, the expected treatment effect is
small, and based on historical insight, it is safe to assume
no carry over effect exists. Usually a “wash-out” period can
be injected in between treatment periods.
3.1 Wash-out Period
This approach calls for a “wash-out” period after the end
of the first period, where all users will receive the control.
Data from the wash-out period can be analyzed in similarly
in linear mixed model to estimate the carry over effect and
subsequently inform the design of later stage. We leave this
as an exercise to the reader.
3.2 Estimate Carry over Effect
In the crossover design where only two groups are allocated,
it is not hard to see that potential carry over effect is con-
founded with the week to week difference of treatment ef-
fect. Using only the crossover model, we can only measure
one of these two effects. As an alternative, at the cost of
less efficiency gain over the traditional non-crossover design,
we may estimate the carry over effect explicitly using the
following 4-group design.
In a 4-group re-randomized design, we conduct the experi-
ment over two periods, and split the users into four equally
sized groups, one receiving controls in both periods, one re-
ceiving treatments in both, and one receiving treatment fol-
lowed by control, and the last receiving control followed by
treatment, we can then tease apart carry over effect and
treatment effect. We call this the re-randomized design, as
it is equivalent to having another round of user randomiza-
tion between the first and the second period. Using notation
from the linear mixed model, the model considering a po-
tential carry over effect α is then
C
T
−
T
C
−
C
C
−
T
T
 :

X1
X2
Y 1
Y 2
Z1
Z2
W1
W2
 ∼ N
(
µ
δ+µ+θ
δ+µ
α+µ+θ
µ
µ+θ
δ+µ
δ+µ+θ
 ,
[
Σ 0 0 0
0 Σ 0 0
0 0 Σ 0
0 0 0 Σ
])
,
Σ =
[
s21 ρs1s2
ρs1s2 s
2
2
]
The carry over effect is in the group that received first treat-
ment and then reverted back to control in the second stage.
Using observed data we can estimate carry over effect α as
an additional term in ~β. When α is not statistically signifi-
cant under pre-specified type I error cutoff (usually 0.05), it
is safe to drop the term α from ~β, and re-fit the model. This
way, we gain one more degree of freedom and thus reduces
variances in the MLEs.
This approach enables direct estimation of carry over effect.
It can also be considered a hybrid approach between the
crossover and parallel design, as half of the users received
crossed treatments, and half received the same treatments
in the two periods. It is not hard to see this design will
achieve sensitivity improvement between the crossover and
parallel designs.
4. MISSING VALUES AND METRICS BE-
YOND AVERAGE
4.1 Loss of follow-up and intent to treat
Loss of follow-up is a common term in clinical studies. It
refers to patients who were active participants during some
period of the trial, but stopped participating at some point
of follow-up. This can lead to incomplete study results and
potential bias when the attrition is not random. Intention-
to-treat analysis is commonly employed, when the subjects’
initial assigned treatment is used regardless of actual re-
ceived treatment. In online A/B testing the idea is similar;
users are assigned to treatment groups at some point in time
before the experiment starts, often by user id, but may or
may not appear in the actual duration of the experiment.
This missing pattern is far from random, therefore methods
that rely on strong MCAR assumption (missing completely
at random) are not appropriate and even MAR (missing at
random) assumption is questionable as it requires missing
pattern to be random conditioned on observed covariates.
One way to see measurements are not missing at random is
to realize infrequent users are more likely to have missing
values and the absence in a specific time window can still
provide information on the user behavior and in reality there
might be other factors causing user to be missing that are
not even observed. Instead of throwing away data points
where user appeared in only one period and is exposed to
only one of the two treatments, in practice, we included an
additional indicator for whether or not the user appeared in
the study in the period.
Specifically, we use an additional indicator for the pres-
ence/absence status of a user in each experimentation pe-
riod. For user j in period i, let Iij = 1 if user j appears in
period i, and 0 otherwise. For each user j in period i, in-
stead of one scalar metric value (Xij), we augmented it into
a vector (Iij , Xij). When Iij = 0, i.e. user is missing, we
define Xij = 0. Under this simple augmentation, the metric
value Xi for period i, taking average over those non-missing
measurements, is the same as
∑
k Xik∑
k Iik
. In this connection, to
obtain MLE and its variance, we only need to estimate the
covariance matrices for each group across time periods, i.e.
Cov(Xi, Xi′) = Cov
(∑
kXik∑
k Iik
,
∑
k′ Xi′k′∑
k′ Ii′k′
)
= Cov
(
Xi
Ii
,
Xi′
Ii′
)
where the last equality is by dividing both numerator and de-
nominator by the same total number of users who have ever
appeared in the experiments. Thanks to the central limit
theorem, the vector (Ii, Xi, Ii′ , Xi′) is also asymptotically
normal. Plugging in observed sample means and covari-
ance matrix, Cov(Xi, Xi′) can be trivially computed with
the delta-method; see Deng et al. (2013, Appendix B) for
a similar example; also see (Van der Vaart 2000) for a text
book treatment of the delta-method.
4.2 Metrics Beyond Average
Treatment groups are assigned to users, but not all metrics
are simple averages across users. We can define a metric as
a function of other metrics. One important family of met-
rics is page level metrics such as click through rate. Page
level metrics use number of page-views as their denomina-
tor. At first glance it might look like just a simple aver-
age. Since treatments are assigned to users (the independent
unit), page-views are therefore not independent. Consider-
ing it as simple average over page level measurements this
needs extra care. A better approach is to see this as a ratio
of two user level metrics: clicks per user and page-views per
user. ∑
useri
Clicksi∑
useri
Pagesi
=
∑
useri
Clicksi/
∑
useri
Ii∑
useri
Pagesi/
∑
useri
Ii
,
where
∑
useri
Ii is the the count of appeared users. The
same delta-method mentioned in Section 4.1 naturally ex-
tends here, with slightly more complicated formula. Since
delta-method applies in general to any continuous function,
we can handle any metric that is defined as a continuous
function of other metrics.
5. FLEXIBLE AND SCALABLE REPEATED
MEASURES ANALYSIS VIA FORME
5.1 Review of Existing Methods
It is common to analyze data from repeated measures design
with the repeated measures ANOVA model and the F-test,
under certain assumptions, such as normality, sphericity (ho-
mogeneity of variances in differences between each pair of
within-subject values), equal time points between subjects,
and no missing data. Such assumptions in general do not
hold for large-scale online experiments, where the assign-
ment of users into different treatment group may not be
completely balanced.
A generally more applicable method is to analyze the data
using the linear mixed effect model, for which complete bal-
ance is not necessary (Bates et al. 2012a). In particular, a
linear mixed effect model treat each measurement of a sub-
ject as a data point, and model the measurement as
Y = θ + αX + βZ + 
Here θ is the global mean and α stands for the vector of all
deterministic fixed effects while β is the vector of all random
effects and  is noise. X and Z are covariates in the model.
In our cases they are indicators of treatment assignment,
periods of the measurement, user id, and any other covariate.
As an example, one possible model for repeated measures
using lme4’s formula syntax (Bates et al. 2012a;b) is
Y ∼ 1 + IsTreatment+ Period+ (1|UserID),
where the only difference of this model to the usual lin-
ear model behind two sample test is the extra random ef-
fect(clustered by UserID) to model user “baseline”. More
complicated models exist to further model interaction and
joint random effects.
Random effect makes modeling within-subject variability
possible. In repeated measures data, users might appear in
multiple periods, represented as multiple rows in the dataset.
As a result, rows of the dataset are not independent but
with dependencies clustered by user. To see this, each user’s
“baseline” measurement is captured as a random effect. The
same user in different period will share the same “baseline”
random effect, therefore resulting in dependency. Mixed ef-
fect model effectively takes advantage of this and is able to
estimate the variance of the random effect while reducing the
variance of average treatment effect. In the case of cross-
over design, the model can take advantage of the positive
correlation between the two periods of the same user, which
improves accuracy in the estimation of treatment effect, sim-
ilar to the illustration we derived in Section 2.4. Treatment
effect can be modeled as either a fixed effect or random ef-
fect1. If our interest is the average treatment effect, we can
model it as a fixed effect. Note that modeling treatment
effect as fixed effect does not mean we need to assume it is
fixed, which in general is not since different subjects react to
the treatment differently, but rather because the focus here
is the mean of the random treatment effect, not the vari-
ance of the random treatment effect. One can still fit the
model with random treatment effect and the results gener-
ally agree, though fixed effect is believed to be more robust
against model assumptions; see Wooldridge (2012).
We point out two issues of using traditional mixed effect
model, and claim that FORME is a better alternative on
axes of flexibility and scalability.
First, linear mixed effect model (and also generalized linear
mixed effect model) is a family of parametric models, and re-
lies on full knowledge of the likelihood function to perform
parameter fitting. This means the model need to rely on
distributional assumptions such as normality. In particular,
all random effects are typically modeled as normally dis-
tributed or jointly normally distributed. And noise  need
to be either i.i.d normal or the modeler needs to provide a
known covariance matrix. These assumptions are indispens-
able in the theory and pivotal in the fitting of the model.
For our application in online A/B Testing, many of these
assumptions are inappropriate. To name a few, for a metric
like revenue per user, it is inappropriate to model the user
“baseline” revenue per week as normally distributed due to
its large skewness. Also the noise term  is hard to justify to
be truly independent of other random effect. A heavier user
might have bigger “baseline” revenue, and also bigger noise,
and bigger (or smaller in some cases) treatment effect. It
also assumes data are missing at random. Modelers of linear
mixed effect model will need to modify the model by making
random effects jointly random, or including more interaction
terms. However the more complicated the model, the more
questions on model assumptions will arise. We show in Sec-
tion 6 through simulation study, linear mixed effect model
fitted in R package lme4(Bates et al. 2012a) could result in
biased estimation of the average treatment effect when there
is correlation between data missing pattern and user random
effect.
Second, fitting mixed effect model could be expensive. Avail-
able packages in SAS or R are based on fitting MLE or
REML(restricted maximum likelihood). In either case, much
effort is taken to estimate the variance of random effect(s)
or covariance matrix if they are jointly random. Fitting al-
gorithm takes the full dataset with each row representing a
measurement. In online A/B testing, where tens of millions
of users are involved, this dataset could be large. In model
fitting, each iteration requires some operations on this full
dataset. Making the efficiency of model fitting a concern
in big data scenario. To the authors’ best knowledge, there
is no literature on the topic of big data implementation of
1When there are only two measurements for a subject like
crossover design, modeling treatment effect and user “base-
line” both as random effect is unidentifiable. But the model
can be fit if there are more measurements per subject.
linear mixed effect model. In our experience FORME is 1
to 2 magnitudes faster than lme4 with much less memory
footprint even without map-reduce type parallelism.
In the remaining of this section, we explain why FORME
is both more scalable and flexible than linear mixed effect
model.
5.2 FORME is Scalable
Instead of modeling at the level of each individual measure-
ments, FORME sees the problem from a higher level and
take advantage of big data. Based on central limit theorem,
metrics of interest in each period for treatment and control
follows normal distribution. Using the same notation in Sec-
tion 2, this multivariate normal random vector is denoted by
Xi, Y i, i = 0, . . . , 2, with mean ~β(~λ) and certain covariance
matrix. These metric values are correlated with each other
via common user level random effects modeled explicitly in
linear mixed effect model but not in FORME. This is be-
cause when our interest is only in the average treatment
effect, the estimates of those random effects are irrelevant.
Instead, FORME sees the average treatment effect δ as just
one parameter in the mean vector of the metric values ~β(~λ).
That is, when modeling metric values directly using mul-
tivariate normal distribution with parameters in the mean
vector, all the complexities involving the structures of the
random effects are buried in the covariance matrix of multi-
variate normal and we are left with a simple task, which is
to estimate the parameters ~λ of this multivariate normal.
FORME estimates ~λ by fitting MLE. The use of asymptotic
statistics also guarantees that the estimates are normally
distributed with covariance matrix derived from Fisher’s In-
formation (Van der Vaart 2000). Note that the scale of this
step is much smaller than the MLE fitting of a typical linear
mixed effect problem. FORME only need to fit a multivari-
ate normal with small dimension, typically smaller than 12
(6 in a crossover design: treatment and control for each of
the pre-experiment, period 1 and period 2.)
The main computation burden is therefore in the estimation
of covariance matrix. Fortunately, this step only involves
estimation of pair-wise covariance between metric values,
and they all can be map-reduced with one pass of the data.
To handle missing data and general form of metrics (as a
continuous function of other metrics), delta-method can be
employed (Section 4). The application of delta-method only
involves slightly more complicated covariance matrix so we
need to estimate more covariance pairs in one map-reduce
pass of the data, inducing negligible increase in complexity.
5.3 FORME is Flexible
FORME is not only scalable but also more flexible. Because
FORME doesn’t explicitly model random effects as linear
mixed effect models do, FORME makes no distributional
assumptions on random effects and noises . FORME also
make zero assumption on missing data pattern. FORME
needs only one critical assumption , i.e. that central limit
theorem is applicable, which is rarely violated in online A/B
testing, since traffic size is large enough even for the most
highly skewed metrics such as Revenue (Kohavi et al. 2014).
Specifically, FORME can be applied to all these cases:
1. Data can have arbitrary missing pattern. In other
words not assumptions on missing at random.
2. Treatment Effect is random.
3. Treatment Effect and user random effect (baseline) are
not independent.
4. Noises  are not i.i.d.
5. Noise and random effects are not independent.
6. Interactions. (e.g. treatment and control have differ-
ent user random effect distribution, etc.)
To close this section, we make the final remark that the
flexibility of FORME really comes from its simplicity, com-
paring to linear mixed effect model. We believe FORME
is also easier for practitioners to understand. The cost of
FORME to put less assumptions than mixed effect model
is the expectation that when mixed effect model assump-
tions hold, FORME estimate could possess larger variance
than mixed effect model estimate. Next we’ll explore these
through simulation study.
6. RESULTS
6.1 Simulation from Known Distributions
We compare variances reported from our FORME produces
to the traditional linear mixed model under various simu-
lation assumptions. As illustration we used the crossover
design. We simulate a total of 2N users, where N = 10000
and randomly split them into two treatment groups.
Xij = µ+ δij + ui + ij , ij ∼ N(0, σ2)
where i is index for user and j for time period. ij represents
random noises and ui represents random user “baseline” ef-
fect. δij is the treatment effect for user i in period j (0 if not
in treatment). In this model, the between period correlation
is then σ
2
σ2u+σ
2 . If user i is in treatment for time period j,
δij ∼ N(δ, σ2δ )×pi, where δ×E(pi) is the ground truth aver-
age treatment effect size, pi is a continuous value between 0
and 1, and it represents the user’s activity level. We designed
pi to be correlated to ui. This way we allow treatment effect
to vary by how frequent a user visits the site. Finally we al-
low Xij to be missing with probability of max(90%, 1− pi).
This is intuitive since a less active user would be missing
more often. Note that in this simulation study we know
exactly what the true average treatment effect is. We sim-
ulated this process K = 10000 times so that we can have
a good estimate of the ground truth variance of treatment
effect estimated by FORME and mixed effect model (lme4).
We want to learn the following for both FORME and lme4
from this simulation study: 1) is estimate unbiased, 2) is
variance estimation correct. If both methods are unbiased,
then we want to know which one has smaller variance. With-
out loss of generality, we used µ = 0, σ = 4, σu = 2 or 4,
δ = 10, and σδ = 0.1
√
12. We chose 5 simulation conditions
as the following:
1. Normal noise, no treatment effect, normal user random
effect ui ∼ N(0, σ2u)
2. Normal noise, no treatment effect, Poisson user ran-
dom effect ui ∼ Poisson(σ2u)
3. Normal noise, with random treatment effect that is
correlated with user random effect: N(δ, σ2δ )× pi
4. Noise is correlated with User activity level: σ = 2× pi
5. Noise is correlated with User activity level: σ = 4× pi
and all conditions have roughly 50% user missing in each
period.
First of all in condition 3 when there is a random treat-
ment effect, we found lme4 consistently gave biased esti-
mation(when ground truth effect is 6.6, FORME estimates
are very close to ground truth while lme4 always gave bi-
ased estimation around 7.2). This is because lme4 relies on
the assumption of missing at random, and it is violated as
random effect is negatively correlated to the chance of miss-
ing. We believe this is a fundamental problem issue with
mixed effect model as missing data pattern is often corre-
lated with some underlying user characteristics that is cor-
related with user’s response to treatment. One might argue
that mixed effect model can be fixed by throwing more inter-
action terms. However in practice more complex models are
often not identifiable (parameters more than data points)
and they only makes more assumptions. We also noted that
except for condition 3, lme4 provided unbiased estimates for
condition 2, 4 and 5 where some assumptions in mixed ef-
fect model are violated. We believe central limit theorem
also helped in this case for lme4 to stay unbiased. But bias
in condition 3 seems to be more fundamental. We leave a
more thorough study of the bias of lme4 with violation of
different assumptions in future work.
We also compared variance in LME and FORME under the
crossover model below in Figure 1. Both FORME and lme4
provided very good estimation of variance. And also as ex-
pected FORME pays a price for its flexibility and almost
“model free” as variance from lme4 estimations are gener-
ally smaller. The variance gap is bigger when missing rate is
higher and between-periods correlation is higher. Although
not shown, in the conditions when either there is no miss-
ing data, or the correlation is 0, FORME and lme4 estimates
have the same variance. Although lme4 estimate has smaller
variance, its potential bias is a show-stopper since for treat-
ment effect estimation a low variance estimate is not useful
if biased.
Figure 1: Effect Variance in LME and FORME
6.2 Simulation from Empirical Data
Next we randomly sampled from our in-house data a small
subset of N = 1250 users, randomly split the users into
equal sized subsets, and applied various designs. We then
simulate K = 10000 bootstrap samples (with replacement)
from this dataset, fit FORME and report estimated MLEs.
The variance based on these MLEs are then compare to
the variance estimated from Fisher Information using the
full dataset. Figure 2 shows the two agrees well. Note the
cumulative effect had different effect size from the rest of the
designs. For this particular metric, using CUPED results in
roughly 50% reduction in variance. Crossover design shows
reduction of around 50% compare to the parallel design.
Figure 2: Effect Variance from Fisher’s Information
and Bootstrap method
6.3 Real Experiments
Finally, we report results from three typical metrics in one
of our real experiments. Here we used percent change as
the effect size. This way, weekly effect size is comparable
to cumulative effect size across two weeks. The variance of
effect size therefore indicates sample size needed to achieve
the same sensitivity. Figure 3 displays the percent samples
needed to achieve the same sensitivity for three metrics us-
ing various models, with the crossover design as baseline.
Therefore crossover design had value of 100. All models
included CUPED since pre-experiment data always exists
and is free. The crossover design consistently had the fewest
samples needed. Next the re-randomize design had value be-
tween crossover and the parallel design. Cumulative design
follows. When the re-randomize model includes a leftover
effect, the samples needed can be larger than cumulative
design for metric 2. Note that compared to the previous
benchmark, the cumulative design, the crossover design can
save up to 2/3 the traffic for metric 3, while for others, the
traffic savings is in the 30-40% range. This is due to inher-
ent difference in week to week correlation in different met-
rics. Note the drastic reduction in variance for such metrics
means the same feature can be tested with only 1/3 of the
original traffic!
7. PRACTICAL CONSIDERATIONS
At the design stage, we face a few choices under the same
framework of repeated measures design. Experimenters should
use domain knowledge and past experiments to inform the
design. This is rather an art than pure science. Here we
give guidelines according to our own experience.
7.1 Recommended Work Flow
Due to the flexibility in a two-stage setup in repeated mea-
sures design, we can use the information gathered in the
first stage to inform procedures in the next stage. We rec-
ommend using crossover design as validation stage experi-
ments, for which we already have gathered exploratory di-
rectional data. If the first stage already result in statistical
Figure 3: Percent samples needed to achieve the
same sensitivity for four metrics. Baseline is the
crossover design.
significance in KPI, we may choose to terminate the experi-
ment already. However in practice, we generally recommend
running the experiments long enough to gain enough power
for not only the KPI, but other metrics designed to moni-
tor data quality and serve as guardrail against unexpected
changes.
Otherwise, in running the second stage, we can use domain
knowledge to inform about carry over effect. If historical
experiments in similar feature iterations indicate potential
carry over effect, we recommend running a complete 4-group
crossover experiment, so we can directly estimate carry over
effect. Otherwise, we recommend using the 2-group cross-
over design to achieve the maximum power for KPI. If we
are not sure, it is still possible to leave a few days’ “wash-
out” period after completing the first stage, and see if any
carry over effect can be observed.
• No swapping: When it is critically important to en-
sure consistent users experience, such as changing the
entire layout of a site, it may not be desirable to show
users the new site for a week, and then swap them back
to the old site. The experience may be too jarring to
users and hurt the brand. In such cases, we do not
recommend re-assigning treatment variants half way
through.
• Crossover: Relatively small changes that are less di-
rectly noticeable are better candidates for treatment
swapping. If similar experiments from the past, or
earlier exploration data do not indicate the presence of
carryover effect, the crossover design can be employed.
• Re-randomized: If we suspect the presence of car-
ryover effect, the re-randomized design enables us to
measure it directly and should be used here.
• Wash-out and decide: If we have little informa-
tion to judge carry over effect, we can run the first
week of the experiment, and then leave a few days as
a “washout” period. The next stage is data driven.
Using such data we can estimate the carry over effect
explicitly.
– If there is no significant carry over effect, proceed
as the crossover design.
– Otherwise, proceed as the re-randomized design.
Having collected experiment data, they can then analyzed
in the following work flow to achieve the most power.
No swapping:
– Test equivalence of treatment effect across time
– If they are equivalence, report treatment effect in
the “per time unit” metric values by analyzing us-
ing the parallel model, including pre-experiment
data.
– Otherwise, analyze only cumulative effects, and
including pre-experiment data. Note this is CUPED.
Crossover design:
– Test equivalence of treatment effect across time
– If they are equivalence, report treatment effect in
the “per time unit” metric values by analyzing us-
ing the crossover model, including pre-experiment
data.
– If, however, unexpected significant difference is
found, you have several choices
∗ Report the two treatment effects separately
∗ To understand the difference properly, an-
other phrase of the experiment can be added,
using re-randomized design. With a total of
three weeks’ data, we can see whether the
treatment effect difference is due to true week-
to-week to difference, and study its trend, or
due to carry over effect.
Re-randomized design:
– Test equivalence of treatment effect across time
and presence of carryover effect
– Reduce the model if any of the effects are not sta-
tistically significant, and report treatment effect.
This carries the subtle difference of reporting a treatment
effect in the entire duration of the experiment, versus that
per time unit (a week here). We argue that as long as weekly
treatment effects are stable over time, reporting weekly ef-
fect is intuitive, easy to understand, and easy to compare
across different experiments. In real life, various things can
happen during an experiment, and we may end up with an
experiment that ran only in partial weeks. In these cases, re-
porting treatment effect in the entire duration will be better
than throwing away data or ignore weekdays difference.
7.2 Sample Size Considerations
While direct estimation in sample size is difficult in the linear
mixed model, in practice there is an easy work around. In
the traditional design, using CLT, with a simple two-sided
test for H0 : δ = 0, sample sizes can be easily calculated.
n = (z1−α/2 + z1−β)
2/
δ2
V ar(δ)
where α is the allowed false positive rate, usually 0.05, and
1− β is the desired power, usually at 80% to 90%.
From historical data we can record the amount of variance
reduced for each metric. The magnitude is determined by
inherent variance in the metric, and correlation across time
periods, both of which are observed to be fairly stable across
many experiments. Suppose the variance for metric X in
crossover experiment is k% that in the conventional t-test.
If N subjects are required to detect a change of δ% in t-test
with, say, 80% power, then k%N is the reduced sample size
to achieve the same power.
8. DISCUSSIONS AND FUTURE WORK
8.1 Extending to more frequent swaps
The crossover design achieves sensitivity by exposing users
to both treatment variants in sequence, by swapping the
treatment assignment once during the experiment. Using
each subject as his or her own control and this design to
account for within-subject variance. A natural extension
of the idea is to swap treatment groups more than once.
Essentially, this changes to a more granular randomization
unit, from users to page views. Exploratory work shows this
indeed achieves further variance reduction.
However, this also raises the concern for inconsistent user ex-
perience, diminished treatment effect size, stronger learning
effect, and lack of a longer term measure. Despite these con-
cerns, it remains a valuable option in early stage experiments
to quickly select promising features for further iteration.
8.2 Limitations and concerns
Due to user behavior differences between weekday and week-
ends, we usually recommend running each phase of the cross-
over design for at least a full week. A crossover experiment
then requires two complete weeks to gather data, which hin-
ders agility. Another limitation is that for very highly visible
features like changing prominent UI features, such swapping
may not be desirable since it may confuse the users. Finally,
not all features can be tested this way, as there might be
a “learning” effect, where we can’t have the users exposed
to treatment “unlearn” the feature, while having controls
naive to the treatment. For example, if the website provides
new features and personalized content to signed in users to
encourage higher rate of signing in and staying signed in.
These users cannot then be forced to logout into the control
group. Ma et al. (2011) shows one interesting case where
crossover design can be extended to tackle this issue.
8.3 Further Improvements of FORME
We’ve shown in Section 6.1 that mixed effect model via lme4
provides a competing estimate of the average treatment ef-
fect that could be biased when missing data pattern corre-
late with user random effect, but often with smaller variance
than FORME. We noted that FORME has to pay some price
to be more flexible and robust, similar to nonparametric
model usually is less efficient than their parametric coun-
terparts. However we suspect that efficiency of FORME
can be further improved to match the efficiency of mixed
effect model even under perfect mixed effect model assump-
tion. Such improvement would be very desirable. But even
without such improvement we believe the bias when there
is missing data that is not missing at random is a big issue
for mixed effect model to be adopted in online controlled
experiment. And FORME should be used instead.
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